Scopa James Paul

CIK 000135695015 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001356950

Recent Transactions

50 trades

Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−4,500→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−10,450→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−4,000→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−10,520→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−4,666→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−3,000→ 0 total
Disposition from Tender
Adverum Biotechnologies, Inc.
Common Stock
2025-12-09−10,333→ 0 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2025-06-25+5,860→ 5,860 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+10,450→ 10,450 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-06-27+60,000→ 60,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2024-06-17+10,520→ 10,520 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+8,823→ 8,823 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−30,000→ 0 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2024-02-07$1.35/sh+100,000→ 100,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Common Stock
2023-10-25$0.76/sh+183,083→ 183,083 total
Award
Aligos Therapeutics, Inc.$ALGS
Warrant (Right to Buy)
2023-10-25$0.13/sh+91,541→ 91,541 total
Disposition to Issuer
DICE Therapeutics, Inc.
Stock Option (right to buy)
2023-08-09−13,800→ 0 total
Disposition to Issuer
DICE Therapeutics, Inc.
Common Stock
2023-08-09−25,722→ 0 total
Disposition to Issuer
DICE Therapeutics, Inc.
Stock Option (right to buy)
2023-08-09−8,261→ 0 total
Disposition to Issuer
DICE Therapeutics, Inc.
Common Stock
2023-08-09−15,199→ 0 total
Disposition to Issuer
DICE Therapeutics, Inc.
Stock Option (right to buy)
2023-08-09−21,250→ 0 total
Disposition to Issuer
DICE Therapeutics, Inc.
Stock Option (right to buy)
2023-08-09−12,096→ 0 total
Gift
DICE Therapeutics, Inc.
Common Stock
2023-08-02−220→ 27,922 total
Gift
DICE Therapeutics, Inc.
Common Stock
2023-08-02−2,200→ 25,722 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-07-20+20,000→ 20,000 total
Gift
DICE Therapeutics, Inc.
Common Stock
2023-07-18−2,200→ 28,142 total
Gift
DICE Therapeutics, Inc.
Common Stock
2023-07-11−300→ 30,342 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2023-06-09+40,000→ 40,000 total
Gift
DICE Therapeutics, Inc.
Common Stock
2023-05-01+6,923→ 30,642 total
Gift
DICE Therapeutics, Inc.
Common Stock
2023-05-01−6,923→ 15,199 total
Sale
DICE Therapeutics, Inc.
Common Stock
2023-03-17$29.05/sh−10,000→ 23,719 total
Gift
DICE Therapeutics, Inc.
Common Stock
2022-10-24+30,719→ 33,719 total
Gift
DICE Therapeutics, Inc.
Common Stock
2022-10-24−30,719→ 22,122 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-06-23+15,000→ 15,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2022-06-10+40,000→ 40,000 total
Award
DICE Therapeutics, Inc.
Stock Option (right to buy Common Stock)
2022-06-07+21,250→ 21,250 total
Gift
DICE Therapeutics, Inc.
Common Stock
2021-12-30+3,000→ 3,000 total
Gift
DICE Therapeutics, Inc.
Common Stock
2021-12-30−3,000→ 52,841 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2021-11-15$2.18/sh−50,000→ 3,334 total
Purchase
DICE Therapeutics, Inc.
Common Stock
2021-09-15$17.00/sh+6,000→ 55,841 total
Award
DICE Therapeutics, Inc.
Stock Option (right to buy)
2021-09-14+8,261→ 8,261 total
Award
DICE Therapeutics, Inc.
Stock Option (right to buy)
2021-09-14+5,600→ 5,600 total
Award
DICE Therapeutics, Inc.
Stock Option (right to buy)
2021-09-14+12,096→ 12,096 total
Award
DICE Therapeutics, Inc.
Stock Option (right to buy)
2021-09-14+8,200→ 8,200 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2021-05-12+40,000→ 40,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2021-04-26+30,000→ 30,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-06-23+30,000→ 30,000 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-05-04−23,334→ 46,666 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-05-04$6.48/sh+23,334→ 53,334 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2020-02-14$13.75/sh+10,000→ 30,000 total

Companies

Recent Filings

Address

C/O MPM ASSET MANAGEMENT 601 GATEWAY BLVD., SUITE 350

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov